Brooke Story - Jun 14, 2021 Form 3 Insider Report for Sigilon Therapeutics, Inc. (SGTX)

Role
Director
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
Stock symbol
SGTX
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
3
Date filed
6/16/2021, 04:05 PM
Next filing
May 27, 2022

No securities are beneficially owned.